As Published By
ALAN S. RIPKA, ESQUIRE
The U.S. Food and Drug Administration ordered makers of hip replacement implants to study whether its implants raise the level of metal in patients’ blood to dangerous levels. The failure rates of the implants have prompted recalls and increased regulator inspection. The high level of metal in blood can lead to effects on the heart, nervous system, and thyroid gland, and may be related to increased pain, tissue damage and the need for repeat surgeries to fix failing hip implants.
On May 6, 2011, the FDA sent the request to Johnson and Johnson and other device makers, asking them to study the levels of cobalt and chromium in patients for at least eight years after implantation. The producers have 30 days to file a proposed plan with the F.D.A, and the companies are asked to sample patients to determine the levels of metal in their blood, and to establish how frequently the devices fail.
Nine months ago, DePuy Orthopaedics recalled a hip- replacement system that had been implanted in 93,000 patients worldwide. In March, the British Orthopaedic Association reported that one model of all-metal hip made by Johnson and Johnson was projected to fail in half of the patients who received it within six years after implant.
If you or a loved one has suffered from symptoms or repeat surgeries due to metal-on-metal hip replacement, you may be entitled to compensation. Alan Ripka and his professional team of lawyers can evaluate your situation and determine the next steps to gain justice for you and your family. Alan Ripka has fought against large companies in other matters and will fight for you if we believe you have a potential case for medical malpractice, products liability, personal injury, and is prepared to go to court and have a trial if necessary. Please call or contact Alan Ripka.
